dextromethorphan hydrobromide; guaifenesin; naproxen sodium
Drug data last refreshed 10h ago · AI intelligence enriched 1mo ago
MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM is an oral extended-release tablet combining dextromethorphan (cough suppressant), guaifenesin (expectorant), and naproxen sodium (NSAID pain/fever reliever) for multi-symptom cold management. It is designed to provide 12-hour symptomatic relief of cough, congestion, pain, and fever associated with the common cold.
Early-stage OTC launch with minimal established market data; commercial teams face greenfield opportunity to build category awareness and establish shelf position in crowded cold-and-flu segment.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on MUCINEX 12HR COLD & FEVER offers opportunity to lead a newly launched OTC product with significant white space in the cold-and-flu category. Career trajectory emphasizes commercial excellence, retail marketing strategy, and rapid scaling in a high-volume, price-sensitive consumer segment with direct-to-retailer and direct-to-consumer channels.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo